Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy

被引:2
|
作者
Solans, R
Bosch, JA
Galofré, P
Porta, F
Roselló, J
Selva-O'Callagan, A
Vilardell, M
机构
[1] Vall dHebron Gen Teaching Hosp, Dept Internal Med, Barcelona, Spain
[2] Vall dHebron Gen Teaching Hosp, Dept Nucl Med, Barcelona, Spain
[3] Vall dHebron Gen Teaching Hosp, Dept Epidemiol & Prevent Med, Barcelona, Spain
关键词
salivary glands; lacrimal glands; xerophthalmia; xerostomia; radioiodine therapy; thyroid cancer;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Salivary gland dysfunction has been described in patients undergoing radioiodine therapy but associated lacrimal gland dysfunction (sicca syndrome) has never been reported. We conducted a prospective cohort study with follow-up for up to 3 y in a tertiary care university center to determine the prevalence of sicca syndrome in patients after high-dose radioiodine treatment. Methods: From January 1990 to December 1995, all patients undergoing radioiodine therapy (n = 79) with a standard dose of 925 MBq to 18.5 GBq (25-500 mCi) were interviewed using a standardized questionnaire to determine subjective ocular and oral dryness and were examined for objective lacrimal and salivary gland dysfunction. Results: After radioiodine treatment, 32.9% of the patients reported subjective xerostomia and 25.3% reported subjective xerophthalmia in the first year of follow-up. Xerostomia persisted to the second year of follow-up in 20.3% of cases and was still present >3 y after the last dose of radioiodine in 15.2% of cases. Xerophthalmia persisted to the second year of follow-up in 17.7% of cases and was still present in the third year of follow-up in 13.9% of cases. Severe xerostomia occurred in 4 patients. Reduced salivary and lacrimal gland function was documented in 40 (50.6%) and 14 (17.7%) of the 79 cases, respectively, in the first year of followup. Objective xerostomia persisted in 13.9% of cases to the second year of follow-up and was still present in all patients >3 y after the last radioiodine application. Keratoconjunctivitis sicca persisted in 11 patients (13.9%) to the second year of follow-up but was only present in 6 patients (7.6%) >3 y after the last radioiodine application. Additionally, 28/79 patients (35.4%) who had a normal salivary gland scintigraphy previously showed reduced salivary gland function in the third year of follow-up. No significant dependence on cumulative treatment was found for objective xerostomia or xerophthalmia, but doses >11.1 GBq (300 mCi) were related to stage 3 dysfunction on salivary gland scintigraphy, Conclusion: Salivary and lacrimal gland dysfunction (sicca syndrome) is relatively frequent after radioiodine therapy. In most cases this is a transient side effect, but in some patients it may persist for a long period or appear late.
引用
收藏
页码:738 / 743
页数:6
相关论文
共 50 条
  • [31] Discrepant salivary gland response after radioiodine and MIBG therapies
    Jentzen, Walter
    Richter, Marion
    Poeppel, Thorsten D.
    Schmitz, Jochen
    Brandau, Wolfgang
    Bockisch, Andreas
    Binse, Ina
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 61 (03): : 331 - 339
  • [32] Relationship between lemon sucking and salivary gland damage after radioiodine therapy for thyroid cancer
    Yilmaz, S.
    Kabasakal, L.
    Dumlu, A.
    Elcin, M. A.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S413 - S414
  • [33] Nasal Symptoms After Radioiodine Therapy: A Rarely Described Side Effect with Similar Frequency to Lacrimal Dysfunction
    Jonklaas, Jacqueline
    THYROID, 2014, 24 (12) : 1806 - 1814
  • [34] Radioiodine therapy affects lacrimal gland function: A cross sectional study.
    Zettinig, G
    Hanselmayer, G
    Fueger, B
    Nepp, J
    Schild, G
    Flores, J
    Becherer, A
    Passler, C
    Dudczak, R
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 158P - 158P
  • [35] Radioiodine therapy affects lacrimal gland function: A cross-sectional study
    Hanselmayer, GH
    Zettinig, G
    Fueger, B
    Hofmann, A
    Schild, G
    Schmidinger, G
    Nepp, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U14 - U14
  • [36] Evaluation of Salivary Gland Dysfunction Using Salivary Gland Scintigraphy in Sjögren's Syndrome Patients and in Thyroid Cancer Patients after Radioactive Iodine Therapy
    Kang J.Y.
    Jang S.J.
    Lee W.W.
    Jang S.J.
    Lee Y.J.
    Kim S.E.
    Nuclear Medicine and Molecular Imaging, 2011, 45 (3) : 161 - 168
  • [37] USEFULNESS OF THE MAYOR SALIVARY GLAND ULTRASONOGRAPHY IN THE EVALUATION OF THE PATIENT AFFECTED BY SICCA SYNDROME
    Bello, S.
    Bonali, C.
    Maiorano, E.
    Di Giuseppe, P.
    Terlizzi, N.
    Rotondo, C.
    Serafino, L.
    Minosi, A.
    Lapadula, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 552 - 552
  • [38] Salivary gland ultrasound features in sicca syndrome secondary to immunotherapy with checkpoint inhibitors
    Bourgeois, Camille
    Sanchez Lucas, Marina
    Rodriguez Merlos, Pablo
    Nieto-Gonzalez, Juan Carlos
    Alvaro-Gracia, Jose Maria
    Molina-Collada, Juan
    CLINICAL RHEUMATOLOGY, 2024, 43 (12) : 3999 - 4001
  • [39] Protective effects of curcumin on radioiodine-induced salivary gland dysfunction in mice
    Kim, Jeong Mi
    Kim, Ji Won
    Choi, Mi Eun
    Kim, Seok-Ki
    Kim, Young-Mo
    Choi, Jeong-Seok
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2019, 13 (04) : 674 - 681
  • [40] SALIVARY-GLAND CHANGES AND LACRIMAL FUNCTION IN CHRONIC FATIGUE SYNDROME
    PAPADATOS, S
    SIROIS, D
    DOYLE, J
    MESA, M
    SCHNEIDER, L
    NATELSON, B
    JOURNAL OF DENTAL RESEARCH, 1994, 73 : 421 - 421